Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancer
Sahar Nissim(Harvard University), Wolfram Goessling(Brigham and Women's Hospital), Jerry R. Heidel(Oregon State University), Christopher A. Cassa(Brigham and Women's Hospital), Karen Cichowski(Brigham and Women's Hospital), Alec C. Kimmelman(New York University), Bethany Unger(Medical College of Wisconsin), Benjamin C. Jennings(University of Michigan), João A. Paulo(Harvard University), Matthew B. Greenblatt(Hospital for Special Surgery), Ellen Lorimer(Medical College of Wisconsin), J. Wade Harper(Harvard Stem Cell Institute), Jill A. Rosenfeld(Baylor College of Medicine), Patrick Gonyo(Medical College of Wisconsin), Andrew G. Cox(The University of Melbourne), Sebastian Gableske(Dana-Farber Cancer Institute), Ignaty Leshchiner(Broad Institute), Carol A. Fierke(Brandeis University), Shamil Sunyaev(Harvard University), Joseph D. Mancias(Dana-Farber Cancer Institute), Jake Henderson(Brigham and Women's Hospital), Yariv Houvras(Cornell University), Sapna Syngal(Brigham and Women's Hospital), Anthony Brandt(Medical College of Wisconsin), Carol L. Williams(Medical College of Wisconsin), Chinedu Ukaegbu(Dana-Farber Cancer Institute), Jeremy W. Prokop(HudsonAlpha Institute for Biotechnology), Julia Wücherpfennig(Brigham and Women's Hospital), Ophélia Maertens(American Institutes for Research), Xiaoxu Wang(Shanghai Normal University), Gad Getz(Broad Institute), Andrew J. Kim(Brigham and Women's Hospital), John Hedgepeth(Brigham and Women's Hospital)
Cited by 55
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k